Evidence map›Paper›PMID 28275055›Full record

ArticleThe Journal of biological chemistry2017

Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiation.

Shinji Go, Shiori Go, Lucas Veillon, Maria Grazia Ciampa, Laura Mauri, Chihiro Sato, Ken Kitajima, Alessandro Prinetti, Sandro Sonnino, Jin-Ichi Inokuchi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Shinji GoFrom the Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan.
Shiori GoFrom the Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan.
Lucas VeillonFrom the Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan.
Maria Grazia CiampaDepartment of Medical Biotechnology and Translational Medicine, University of Milan, 20090 Segrate Milano, Italy.
Laura MauriDepartment of Medical Biotechnology and Translational Medicine, University of Milan, 20090 Segrate Milano, Italy.
Chihiro SatoBioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, Japan, and.
Ken KitajimaBioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, Japan, and.
Alessandro PrinettiDepartment of Medical Biotechnology and Translational Medicine, University of Milan, 20090 Segrate Milano, Italy.
Sandro SonninoDepartment of Medical Biotechnology and Translational Medicine, University of Milan, 20090 Segrate Milano, Italy.
Jin-Ichi InokuchiFrom the Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan, jin@tohoku-mpu.ac.jp.
Tohoku Medical and Pharmaceutical University · JPUniversity of Milan · ITNagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gangliosides (sialic acid-containing glycosphingolipids) help regulate many important biological processes, including cell proliferation, signal transduction, and differentiation, via formation of functional microdomains in plasma membranes. The structural diversity of gangliosides arises from both the ceramide moiety and glycan portion. Recently, differing molecular species of a given ganglioside are suggested to have distinct biological properties and regulate specific and distinct biological events. Elucidation of the function of each molecular species is important and will provide new insights into ganglioside biology. Gangliosides are also suggested to be involved in skeletal muscle differentiation; however, the differential roles of ganglioside molecular species remain unclear. Here we describe striking changes in quantity and quality of gangliosides (particularly GM3) during differentiation of mouse C2C12 myoblast cells and key roles played by distinct GM3 molecular species at each step of the process.

Indexed as

Cell DifferentiationAnimalsCell ProliferationCeramidesChromatography, High Pressure LiquidChromatography, Thin LayerGlycosphingolipidsG(M3) GangliosideLipidsMass SpectrometryMiceMyoblastsN-Acetylneuraminic AcidSignal TransductionCeramidesGlycosphingolipidsG(M3) GangliosideLipidsN-Acetylneuraminic Acidceramidedifferentiationgangliosidesialic acidskeletal muscle

Identifiers

PMID28275055
PMCPMC5409471
OpenAlexW2592170845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.